Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
Developments in miniaturisation can give us point-of-care tests for grave conditions such as cancer and heart disease.
Labor's shadow health minister Catherine King, said that the government has "cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more". Is that right?
Theranos has had medical laboratory experts scratching their heads for some time. What the company was promising just didn't make a lot of sense.
Humans can only do so much when it comes to diagnosing what's wrong with a patient. So why not let machines take over? They learn faster than humans and never retire.
While the extent of the problem is unclear, we know that hospitals doctors overuse diagnostic tests. Involving patients in decision-making may be one of the best options for improving the situation.